Cas 407622-47-3,4-(4-chlorobenzoyl)-1-[4-(4-pyridinyl)benzyl]-1,3,4,5-tetrahydrobenzo[e][1,4]diazepin-2-on Mono(trifluoroacetate)

407622-47-3

Post Buying Request

Basic information

Product Name: 4-(4-chlorobenzoyl)-1-[4-(4-pyridinyl)benzyl]-1,3,4,5-tetrahydrobenzo[e][1,4]diazepin-2-on Mono(trifluoroacetate)
Synonyms: 4-(4-chlorobenzoyl)-1-[4-(4-pyridinyl)benzyl]-1,3,4,5-tetrahydrobenzo[e][1,4]diazepin-2-on Mono(trifluoroacetate)
CAS NO:407622-47-3
Molecular Formula:
Molecular Weight: 581.979
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-(4-chlorobenzoyl)-1-[4-(4-pyridinyl)benzyl]-1,3,4,5-tetrahydrobenzo[e][1,4]diazepin-2-on Mono(trifluoroacetate)(CAS DataBase Reference)
NIST Chemistry Reference: 4-(4-chlorobenzoyl)-1-[4-(4-pyridinyl)benzyl]-1,3,4,5-tetrahydrobenzo[e][1,4]diazepin-2-on Mono(trifluoroacetate)(407622-47-3)
EPA Substance Registry System: 4-(4-chlorobenzoyl)-1-[4-(4-pyridinyl)benzyl]-1,3,4,5-tetrahydrobenzo[e][1,4]diazepin-2-on Mono(trifluoroacetate)(407622-47-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 407622-47-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

407622-47-3 Suppliers

Recommended suppliers

407622-47-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 407622-47-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,7,6,2 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 407622-47:
(8*4)+(7*0)+(6*7)+(5*6)+(4*2)+(3*2)+(2*4)+(1*7)=133
133 % 10 = 3
So 407622-47-3 is a valid CAS Registry Number.

407622-47-3Upstream product

407622-47-3Downstream Products

407622-47-3Relevant academic research and scientific papers

Benzodiazepine derivatives

-

, (2008/06/13)

The present invention provides benzodiazepine derivatives of the following formula, analogs thereof and pharmaceutically acceptable salts thereof. The compounds of the present invention have an excellent effect of inhibiting activated blood-coagulation factor X. These compounds are usable as agents for treating various diseases concerned with the activated blood-coagulation factor X.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 407622-47-3